| Spirig HealthCare AG - Methylphenidat Spirig HC retard 36 mg, Retardtabletten | | 69315 | | 03 | | Methylphenidat Spirig HC retard 36 mg | | Retardtabletten | | N06BA04 | | Methylphenidat | | 04.01.2024 | | |
| | Composition | | methylphenidati hydrochloridum 36 mg, hypromellosum, macrogolum 200'000, macrogolum 7'000'000, acidum succinicum, magnesii stearas, natrii chloridum corresp. natrium 18.9 mg, silica colloidalis anhydrica, E 172 (nigrum), Überzug: cellulosi acetas, hypromellosum, macrogolum 3350, lactosum monohydricum 6.6 mg, E 171, triacetinum, acidum phosphoricum, pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Methylphenidate Hydrochloride | 36 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Methylphenidate Hydrochloride | 36 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Acide Phosphorique | | | | Acide Succinique | | | | Cellulosi Acetas | | Überzug | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 6.6 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Sodium Chlorure | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 30 | 37.96 | 57.70 | A+ | LS | Non | | 006 | 60 | 66.81 | 89.10 | A+ | LS | Non |
|
|
